Printer Friendly

ANGEION RECEIVES PATENT ON MAPPING TECHNOLOGY

 ANGEION RECEIVES PATENT ON MAPPING TECHNOLOGY
 MINNEAPOLIS, April 9 /PRNewswire/ -- Angeion Corporation


(NASDAQ: ANGN) has been notified by the United States Patent and Trademark Office that a patent application on its mapping technology has been allowed. The patent pertains to the rapid identification of the cells causing ventricular tachycardia (abnormally rapid heartbeats) within an ablation catheter system.
 This mapping technology is currently being utilized in Angeion's clinical trials of its laser catheter for the treatment of ventricular tachycardia. Angeion believes this system of mapping will improve identification of the arrhythmia site, and reduce the current long and tedious process of identifying and altering the cells causing ventricular tachycardia, a potentially life-threatening problem affecting approximately 1.4 million individuals in the United States.
 Angeion currently has 13 patents, of which five patents are for the laser catheter device and mapping technology; and 60 patents pending or in process, of which 22 patent applications are for the implantable defibrillator.
 Minneapolis-based Angeion Corporation is a manufacturer of interventional accessory devices primarily for the cardiovascular markets. Angeion's subsidiaries, AngeLase, Inc. and AngeMed, Inc., are developing products for treating various types of arrhythmias.
 -0- 4/9/92
 /CONTACT: Brenda Roth of Angeion, 612-550-9388/
 (ANGN) CO: Angeion Corporation ST: Minnesota IN: MTC SU: PDT


KH -- MN008 -- 6811 04/09/92 13:10 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Apr 9, 1992
Words:217
Previous Article:COURT SUPPORTS BLOCKBUSTER IN DISPUTE WITH FRANCHISEE
Next Article:GRAHAM-FIELD HEALTH PRODUCTS, INC. TO LIST ON NEW YORK STOCK EXCHANGE


Related Articles
ANGEION RECEIVES THREE MORE PATENTS
ANGEION REPORTS THIRD QUARTER FIGURES
ANGEION CORPORATION ENTERS INTO AGREEMENT WITH SIEMENS PACESETTER, INC.
ANGEION RELEASES SECOND QUARTER FIGURES
ANGEION RECEIVES SEVEN PATENTS
ANGEION REPORTS THIRD QUARTER RESULTS; SECURES INITIAL BRIDGE LOAN
Angeion Receives Suit From Cardiac Pacemakers, Inc.
Cordis Webster to Acquire High Technology Catheter Patents and Distribute Ablation Catheters from Angeion Corporation.
Angeion Reports 33 Percent Growth in ICD Sales in Third Quarter.
Angeion to grant Medtronic non-exclusive license to its patent portfolio.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters